Society for Cardiovascular Angiography and Interventions

At the Society for Cardiovascular Angiography and Interventions Scientific Sessions, I was eating lunch with a group of familiar faces — cardiologists spanning a few generations — when a few current fellows wandered over from the poster session in the exhibition hall.  The report from the abstract presenter: No one came to see her poster. Not one attendee.

SAN DIEGO — Patients with nickel allergy and severe refractory symptoms after implantation with an atrial septal closure device experienced complete resolution of symptoms after device explantation, according to a report presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

SAN DIEGO — Device-related adverse events were rare among children implanted with a transcatheter pulmonary valve, according to new data from the FDA Manufacturer and User Facility Device Experience database.

SAN DIEGO — The most quoted research publications are those that address clinically frustrating scenarios for which we have no answer. Charles Laham, MD, FSCAI, and colleagues attempted to answer such a question with the OUTSIDE START study: That is, what can we do for patients who require interruption to dual antiplatelet therapy after PCI due to urgent and unavoidable surgeries?

SAN DIEGO — Patients with a high–thrombosis-risk paclitaxel-eluting stent who were given cilostazol before undergoing a surgical procedure safely transitioned off dual antiplatelet therapy and had low rates of bleeding and major adverse cardiac events in the perisurgical period, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

SAN DIEGO — In this video, Roxana Mehran, MD, professor of medicine at Icahn School of Medicine at Mount Sinai and associate medical editor of Cardiology Today's Intervention, discusses the Hildner Lecture by Robert Harrington, MD, FSCAI, at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

SAN DIEGO — Implementation of a screening and education program targeting primary care physicians significantly lowered the rate of inappropriate cardiac catheterizations at a rural tertiary care medical center, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

SAN DIEGO — It was previously established in the PLATO trial that ticagrelor is superior to clopidogrel in patients with ACS who were pre-treated with a loading dose. But one question is whether we can extrapolate, as we often do in clinical practice, this finding to troponin-negative patients with an unstable pattern of chest pain.

SAN DIEGO — We all aim to deliver “quality” care to our patients. Sometimes quality is too broadly defined, and physicians and patients may perceive “quality care” somewhat differently. Simply stated, for interventional cardiologists, cath lab teams and our patients, delivering quality care means performing the right procedure for the right patient in the right way.

SAN DIEGO — Use of a pulmonary embolism response service comprised of cardiologists, cardiothoracic surgeons, pulmonologists and radiologists for the care of high-risk patients with pulmonary embolism was associated with improved diagnosis and treatment, researchers reported at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.